In this podcast, Dr. Cassi is joined by Dr. Jocelyn Mott to discuss the use of SGLT2 inhibitors, an exciting new option in the world of feline diabetes mellitus. Their discussion includes mechanism of action of these drugs, practical applications and potential complications, and appropriate monitoring for patients managed with SGLT2 inhibitors. Elanco’s new SGLT2 inhibitor for the management of feline diabetes mellitus, Bexacat™ (bexagliflozin tablets), will also be discussed.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Trump $82 Million Bond Spree, Brazil Tariffs 'Too High,' More
16 Nov 2025
Bloomberg News Now
Ex-Fed Gov Resigned After Rules Violations, Trump Buys $82 Mil of Bonds, More
16 Nov 2025
Bloomberg News Now
THIS TRUMP INTERVIEW WAS INSANE!
16 Nov 2025
HasanAbi
Epstein Emails and Trump's Alleged Involvement
15 Nov 2025
Conspiracy Theories Exploring The Unseen
New Epstein Emails Directly Implicate Trump - H3 Show #211
15 Nov 2025
H3 Podcast
Trump Humiliates Himself on FOX as They Call Him Out
15 Nov 2025
IHIP News